^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    MI FOLFOXai

    Company:
    Caris Life Sci
    Type:
    Laboratory Developed Test
    Related tests:
    Details
    Evidence
    News
    over4years
    Navigate mCRC Standard-of-Care Chemotherapy with MI FOLFOXai Now oncologists have an Artificial Intelligence (AI)-based predictor intended to gauge a mCRC patient’s likelihood of benefit from first-line FOLFOX+BV followed by FOLFIRI+BV versus FOLFIRI+BV followed by FOLFOX+BV. (@JohnFortner5)
    Clinical
    |
    MI FOLFOXai